Javascript must be enabled to continue!
Postoperative Ovarian Reservation Salpingectomy with Ovarian Preservation during Hysterectomy based on AMH Measurement Before and After Surgery: A Systematic Review and M
View through CrossRef
Introduction: To the best of our knowledge, there is no strong evidence for the effect of salpingectomy on the surgical outcome of a standard hysterectomy. Therefore, we decided to conduct a study entitled ovarian reservation after salpingectomy with ovarian preservation during hysterectomy based on AMH measurements before and after surgery as a review until 2019.Materials and Methods: In addition to the 503 studies found in the initial database search, two more studies identified through a reference list of related articles and a Google Scholar search were added. After removing duplicates, the titles and abstracts of the remaining 475 studies were reviewed and 30 studies were selected to review the full text. Then seven studies were deleted and finally 12 studies were reviewed and 11 of them were meta-analyzed.Results: AMH levels before and after salpingectomy were compared with patients in 12 studies. Compared with AMH before salpingectomy, AMH levels after salpingectomy were significantly lower (SMD = -0.35); 95% confidence interval (CI95%): -0.55 - -0.15 (p = 0.001). The results of studies on differences in AMH levels before and after salpingectomy did not show a statistically significant diffusion bias (Egger's P-value = 0.304).Conclusion: The present study showed that the level of AMH hormone was significantly reduced after salpingectomy. One of the limitations of the present study was the lack of surgical complications, the amount of intraoperative bleeding and the duration of surgery in most studies.
Title: Postoperative Ovarian Reservation Salpingectomy with Ovarian Preservation during Hysterectomy based on AMH Measurement Before and After Surgery: A Systematic Review and M
Description:
Introduction: To the best of our knowledge, there is no strong evidence for the effect of salpingectomy on the surgical outcome of a standard hysterectomy.
Therefore, we decided to conduct a study entitled ovarian reservation after salpingectomy with ovarian preservation during hysterectomy based on AMH measurements before and after surgery as a review until 2019.
Materials and Methods: In addition to the 503 studies found in the initial database search, two more studies identified through a reference list of related articles and a Google Scholar search were added.
After removing duplicates, the titles and abstracts of the remaining 475 studies were reviewed and 30 studies were selected to review the full text.
Then seven studies were deleted and finally 12 studies were reviewed and 11 of them were meta-analyzed.
Results: AMH levels before and after salpingectomy were compared with patients in 12 studies.
Compared with AMH before salpingectomy, AMH levels after salpingectomy were significantly lower (SMD = -0.
35); 95% confidence interval (CI95%): -0.
55 - -0.
15 (p = 0.
001).
The results of studies on differences in AMH levels before and after salpingectomy did not show a statistically significant diffusion bias (Egger's P-value = 0.
304).
Conclusion: The present study showed that the level of AMH hormone was significantly reduced after salpingectomy.
One of the limitations of the present study was the lack of surgical complications, the amount of intraoperative bleeding and the duration of surgery in most studies.
Related Results
Is there a relationship between anti-Mullerian hormone (AMH) levels and the prediction of ovarian reserve in reproductive-age women undergoing fertility evaluation? : A Systematic Review
Is there a relationship between anti-Mullerian hormone (AMH) levels and the prediction of ovarian reserve in reproductive-age women undergoing fertility evaluation? : A Systematic Review
Introduction: Accurate assessment of ovarian reserve is crucial for counseling women undergoing fertility evaluation. Anti-Müllerian hormone (AMH) has emerged as a promising biomar...
P-695 Anti-muellerian Hormone (AMH) and Plasminogen Activator Inhibitor (PAI-1) are robust follicular-fluid (FF) biomarkers predictive of follicle maturity and oocyte quality in women undergoing IVF cycles
P-695 Anti-muellerian Hormone (AMH) and Plasminogen Activator Inhibitor (PAI-1) are robust follicular-fluid (FF) biomarkers predictive of follicle maturity and oocyte quality in women undergoing IVF cycles
Abstract
Study question
Is AMH the in-vivo trigger that correlates with PAI-1 in the follicular-fluid micro-milieu to influence ...
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract
The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical activi...
Comparison between antral follicle count and anti-Müllerian hormonal level in the prediction of ovarian response and pregnancy outcome in intracytoplasmic sperm injection patients: implications in personalizing ovarian stimulation
Comparison between antral follicle count and anti-Müllerian hormonal level in the prediction of ovarian response and pregnancy outcome in intracytoplasmic sperm injection patients: implications in personalizing ovarian stimulation
Antral follicle count (AFC) and anti-Müllerian Hormone (AMH) are considered the best markers of ovarian reserve and ovarian response to stimulation. It is not clear whether they co...
P-365 High Impact of Chemotherapy on Ovarian Reserve in Breast Cancer Survivors of Reproductive Age: A Systematic Review and Meta-Analysis
P-365 High Impact of Chemotherapy on Ovarian Reserve in Breast Cancer Survivors of Reproductive Age: A Systematic Review and Meta-Analysis
Abstract
Study question
What is the prevalence of clinically relevant reduced ovarian reserve defined by low anti-Mullerian horm...
SUN-021 Age-Specific Multiples of the Median Level of Serum Anti-Mullerian Hormone Is a Potential Marker for Diagnosis of Polycystic Ovary Syndrome
SUN-021 Age-Specific Multiples of the Median Level of Serum Anti-Mullerian Hormone Is a Potential Marker for Diagnosis of Polycystic Ovary Syndrome
Abstract
Serum anti-Mullerian hormone (AMH) levels are significantly higher in women with polycystic ovary syndrome (PCOS) than in normal ovulatory women. Different ...
Serum anti-Müllerian hormone (AMH) levels correlate with infrarenal aortic diameter in healthy older men: is AMH a cardiovascular hormone?
Serum anti-Müllerian hormone (AMH) levels correlate with infrarenal aortic diameter in healthy older men: is AMH a cardiovascular hormone?
Anti-Müllerian hormone (AMH) is a gonadal hormone present in the blood in men and pre-menopausal women. AMH regulates male sexual differentiation but has no putative function in ad...
Live birth rate after IVF/ICSI in women with low and extremely low AMH: an age-matched controlled study
Live birth rate after IVF/ICSI in women with low and extremely low AMH: an age-matched controlled study
Abstract
Background
An age-matched controlled study, to assess the outcome of IVF/ICSI in low and extremely low AMH levels in different age groups by comparing the live birth rate
...

